COVID-19 cases from the first local outbreak of SARS-CoV-2 B.1.1.7 variant in China presented more serious clinical features: a prospective, comparative cohort study
Yang Song(National Institute for Viral Disease Control and Prevention), Zhihai Chen(Capital Medical University), Ziruo Ge(Capital Medical University), Di Tian(Capital Medical University), Xiang Zhao(Guangdong Polytechnic Normal University), Gang Liu(China Agricultural University), Yu Wang(Harbin Medical University), Wei Zhang(He Eye Hospital), Tingyu Zhang, Shuangli Zhu(National Institute for Viral Disease Control and Prevention), Shuping Cui, Yanhai Wang(National Institute for Communicable Disease Control and Prevention), Xianbo Wang(Capital Medical University), Wenbo Xu(Shenyang Institute of Automation), Gang Wan(Yangtze River Pharmaceutical Group (China)), Yanli Xu(Capital Medical University), Jianbo Tan(Capital Medical University), Long Liu(Beijing Forestry University)
Cited by 1
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k